- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05070624
The Peer Support Study
Connecting Caregivers: A Randomized Controlled Trial to Evaluate Virtual Peer-Support for Family Caregivers of Individuals With Neuromuscular Disease
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Munazzah Ambreen, MD.,MSc
- Phone Number: 4164342542
- Email: munazzah.ambreen@sickkids.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Eligibility Criteria for Peer-Support Program:
Inclusion Criteria
- FC of individual with NMD that lives in Canada;
- Speaks and reads English;
- Access to internet and computer/tablet.
Exclusion Criteria:
We will exclude those Ventilator Assisted Individuals (VAI) and caregivers, who are:
- Unable to communicate verbally in English
- No access to internet and computer/tablet.
Eligibility Criteria for Peer Mentors:
Inclusion Criteria:
- Criteria 1-3 above;
- Completion of virtual peer support training;
- Identified by the HMV team or self-referral.
Exclusion Criteria:
We will exclude those VAIs and caregivers, who are:
- Unable to communicate verbally in English
- No access to internet and computer/tablet.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
After informed consent, we will assign participants in a 1:1 ratio to the intervention or control group using Randomize.net. Participants randomized to intervention group will get access to the Virtual Peer Support Program. |
Training: We have previously developed and beta-tested a virtual peer mentor training program adapted from the St. Jude's Research Hospital's (Memphis, USA) program for FCs of children with cancer for adults using HMV.
Content & Design of the Virtual Peer-Support Program: The program will be delivered by the aTouchAway™ App used for the LIVE program.
Participants will be requested to access peer mentors ≥1 time/week.
Participants can choose to interact with a peer mentor which will be assigned as well as other peer participants.
Onboarding: Participants and mentors will create a personal profile of their caregiving situation (e.g., duration of care, family member age and diagnosis), to enable selection of mentors by the research team believed to be well suited to address support needs, questions, and concerns based on similar lived experience.
|
No Intervention: Control
Control group: Those randomized to the waitlist control will be given access to the peer support intervention on completion of the first 12-week program.
A waitlist control group is an ethical alternative to no-treatment control groups when studying psychological and behavioral interventions 21. will have access to informational resources via the aTouchAway™ App and will also receive the intervention at the end of the trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Family Caregiver (FC) mastery measured using the Pearlin Mastery Scale (PMS)
Time Frame: baseline
|
FC mastery measured using the Pearlin Mastery Scale (PMS) (Pearlin Mastery Scale;(scores range up to 28, higher scores = higher mastery) at baseline,
|
baseline
|
Family Caregiver (FC) mastery measured using the Pearlin Mastery Scale (PMS) at12 weeks
Time Frame: 12 week
|
(FC) mastery measured using the Pearlin Mastery Scale (PMS) at12 weeks (Pearlin Mastery Scale; (scores range up to 28, higher scores = higher mastery)
|
12 week
|
Family Caregiver (FC) mastery measured using the Pearlin Mastery Scale (PMS) at 24 weeks
Time Frame: 24 week
|
(FC) mastery measured using the Pearlin Mastery Scale (PMS) at 24 weeks (Pearlin Mastery Scale; (scores range up to 28, higher scores = higher mastery)
|
24 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Caregiver Competency - measured using the Caregiving Competence Scale
Time Frame: Baseline
|
Caregiver Competency - measured using the Caregiving Competence Scale, The total scores of this 4-item scale ranged from 4 to 16, with higher scores indicating higher levels of caregiving competence
|
Baseline
|
Caregiver Competency - measured using the Caregiving Competence Scale
Time Frame: 12 week
|
Caregiver Competency - measured using the Caregiving Competence Scale, The total scores of this 4-item scale ranged from 4 to 16, with higher scores indicating higher levels of caregiving competence
|
12 week
|
Caregiver Competency - measured using the Caregiving Competence Scale
Time Frame: 24 week
|
Caregiver Competency - measured using the Caregiving Competence Scale, The total scores of this 4-item scale ranged from 4 to 16, with higher scores indicating higher levels of caregiving competence
|
24 week
|
Family Caregiver Burden and Stress - measured using the Zarit Burden Interview
Time Frame: Baseline
|
Family Caregiver Burden and Stress - measured using the Zarit Burden Interview (scores range up to 88, higher scores = higher burden)
|
Baseline
|
Family Caregiver Burden and Stress - measured using the Zarit Burden Interview
Time Frame: 12 week
|
Family Caregiver Burden and Stress - measured using the Zarit Burden Interview scores range up to 88, higher scores = higher burden)
|
12 week
|
Family Caregiver Burden and Stress - measured using the Zarit Burden Interview
Time Frame: 24 week
|
Family Caregiver Burden and Stress - measured using the Zarit Burden Interview scores range up to 88, higher scores = higher burden)
|
24 week
|
Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety Stress Scale
Time Frame: Baseline
|
Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety scores range up to 42, higher scores = higher depression and Anxiety)Stress Scale
|
Baseline
|
Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety Stress Scale
Time Frame: 12 week
|
Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety scores range up to 42, higher scores = higher depression and Anxiety)Stress Scale
|
12 week
|
Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety Stress Scale
Time Frame: 24 week
|
Family Caregiver Depression and Anxiety: measured using the Depression and Anxiety scores range up to 42, higher scores = higher depression and Anxiety)Stress Scale
|
24 week
|
Family Caregiver Experience of the virtual peer support explored using qualitative interviews.
Time Frame: Baseline
|
Family Caregiver Experience of the virtual peer support explored using qualitative interviews.
|
Baseline
|
Family Caregiver Experience of the virtual peer support explored using qualitative interviews.
Time Frame: 12 week
|
Family Caregiver Experience of the virtual peer support explored using qualitative interviews.
|
12 week
|
Family Caregiver Experience of the virtual peer support explored using qualitative interviews.
Time Frame: 24 week
|
Family Caregiver Experience of the virtual peer support explored using qualitative interviews.
|
24 week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTO-3590
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Diseases
-
Brugmann University HospitalCompletedAnesthesia, General | Neuromuscular Transmission DisordersBelgium
-
University Hospital, ToursCompletedNeuromuscular Diseases in Children | Neuromuscular Diseases in InfantsFrance
-
Ottawa Hospital Research InstituteRecruiting
-
University of FloridaTerminated
-
Penwest Pharmaceuticals Co.TerminatedNeuromuscular DiseaseUnited Kingdom
-
Centre d'Investigation Clinique et Technologique...Association Française contre les Myopathies (AFM), ParisCompletedCommunication | Neuromuscular DiseaseFrance
-
National Institute of Nursing Research (NINR)TerminatedNeuromuscular DiseaseUnited States
-
Landon Pediatric FoundationCompleted
-
Institut de Myologie, FranceCompleted
Clinical Trials on The Virtual Peer Support Program
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; MND Association; Marie Curie CharityRecruitingMotor Neuron Disease | Amyotrophic Lateral SclerosisUnited Kingdom
-
VA Office of Research and DevelopmentUS Department of Veterans AffairsCompletedSubstance Use Disorder | Mental Health | Homelessness | Linkage to CareUnited States
-
The Hospital for Sick ChildrenCompleted
-
The Hospital for Sick ChildrenCompletedJuvenile Idiopathic ArthritisCanada
-
The Hospital for Sick ChildrenCompleted
-
University of WashingtonNational Institute of Mental Health (NIMH); Kenyatta National HospitalActive, not recruitingPlanning the mPACT Trial - mHealth Strategies for the Pediatric to Adult HIV Care Transition (mPACT)Transition From Pediatric to Adult HIV CareKenya
-
Johns Hopkins UniversityPatient-Centered Outcomes Research InstituteCompleted
-
Joana Perez TejadaUniversity of the Basque Country (UPV/EHU)RecruitingNeoplasms | Social Skills | Psychological DistressSpain
-
Brigham and Women's HospitalAmgenUnknown
-
Kaiser PermanenteCompleted